反应 #1256771

ord-559d2d17a0874660ade7457a0f51cc54

反应方程式

O=C([O-])O.[Na+]
NaHCO3
Cl.Cl.c1cc2onc(N3CCNCC3)c2cn1
3-piperazin-1-yl-isoxazolo[4,5-c]pyridine dihydrochloride
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CC=O)CC1
trans-[4-(2-oxo-ethyl)-cyclohexyl]-carbamic acid tert-butyl ester
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CC=O)CC1
intermediate H
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CC=O)CC1
trans-[4-(2-oxo-ethyl)-cyclohexyl]-carbamic acid tert-butyl ester
CCN(CC)CC
Et3N
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCN(c3noc4ccncc34)CC2)CC1
title compound
收率 72.2%
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCN(c3noc4ccncc34)CC2)CC1
{Trans-4-[2-(4-Isoxazolo[4,5-c]pyridin-3-yl-piperazin-1-yl)-ethyl]-cyclohexyl}-carbamic acid tert-butyl ester
收率 72.2%

溶剂

反应条件

详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    萃取the product was extracted with 2 portions of CH2Cl2
  2. 2
    其他After drying
  3. 3
    其他(MgSO4) and evaporation of the solvent the product
  4. 4
    其他was purified by flash chromatography (50 g SiO2, EtOAc/MeOH 100:0→80:20)

实验过程

A solution in CH2Cl2 (10 ml) of 3-piperazin-1-yl-isoxazolo[4,5-c]pyridine dihydrochloride (840 mg, 3.0 mmol) and trans-[4-(2-oxo-ethyl)-cyclohexyl]-carbamic acid tert-butyl ester (904 mg, 3.7 mmol; intermediate H; prepared according to WO2007/093540) was treated with Et3N (629 mg, 6.2 mmol) before addition of Na(AcO)3BH (1.03 g, 5 mmol). The reaction mixture was stirred 16 h at r.t., then sat. aq. NaHCO3 was added and the product was extracted with 2 portions of CH2Cl2. After drying (MgSO4) and evaporation of the solvent the product was purified by flash chromatography (50 g SiO2, EtOAc/MeOH 100:0→80:20) to obtain 930 mg (71%) of the title compound as an off white solid. m/z=430.3 ([M+H]+).

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US07825123B2uspto-grants-2010_11